New Catheter-Based valve replacement offers hope for High-Risk heart patients
NCT ID NCT07130994
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a new device called the SATURN TS TMVR System, which is implanted through a catheter to replace the mitral valve in people with severe mitral regurgitation. Up to 15 patients who are too high-risk for open-heart surgery will be enrolled. The goal is to see if the device can be safely implanted and reduce the backward flow of blood in the heart.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SATURN TS TMVR System (a device implanted via catheter to replace the mitral valve)
What this could lead to
If successful, this could offer a less invasive treatment option for people with severe mitral regurgitation who are too high-risk for open-heart surgery.
What could go wrong
This is a very early feasibility study with only 15 participants, so results may not apply widely. The procedure carries risks like stroke, heart damage, or need for reintervention.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Contact Email: •••••@•••••
Contact
-
Columbia University Irving Medical Center/New York Presbyterian Hospital
New York, New York, 10032, United States
Contact
Contact Email: •••••@•••••
-
Los Robles Regional Medical Center
Thousand Oaks, California, 91360, United States
Contact Email: •••••@•••••
Contact
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Contact Email: •••••@•••••
Contact
-
UC Davis Health
Sacramento, California, 95817, United States
Contact
Contact Email: •••••@•••••